~~<i id='1329FAFE21'><strike id='1329FAFE21'><tt id='1329FAFE21'><pre id='1329FAFE21'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

hotspot

author：explore 2025-09-09 19:29:15 - browse：63763

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

knowledge

focus

knowledge

hotspot

AdobeHumana’sMedicareAdvantageenrolleesgotcareinthehospitalandphysicianclinicswaymoreoftenthanthecom

WSS

Think you might have Covid

Judge rejects Trump's request to move Stormy Daniels hush

Indian pharmaceutical industry in denial over drug

Mass General totes up its waste in a move to tackle climate change

Think you might have Covid

Vir antibody drug aimed at influenza A fails in clinical trial

leisure time

hotspot

knowledge

Jerome Adams on the need for new antivirals for Covid

Prior authorization will have to move faster under new Biden rule

Heart attack and stroke risk calculators need revising

I learned firsthand about improving diversity in clinical trials

Duchenne breakthrough therapy leaves behind pioneering families

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

7 more heat

The cancer drug shortage isn’t new — and neither are the solutions

The tragedy of Johnson & Johnson’s Covid vaccine

knowledge

Tesla recalling nearly 16,000 of its 2021

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Awakening the world to the whoosh: A patient's crusade

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Copay coupons to count toward deductibles, after Biden court move

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

focus

knowledge

knowledge

hotspot